Lau Stanley K. 4
4 · Cardio Diagnostics Holdings, Inc. · Filed Jan 2, 2024
Insider Transaction Report
Form 4
Lau Stanley K.
Director
Transactions
- Exercise/Conversion
Restricted Stock Units
2023-12-31Exercise: $0.00From: 2023-12-31Exp: 2024-01-31→ Common Stock - Exercise/Conversion
Restricted Stock Units
2023-12-31Exercise: $0.00From: 2023-12-31Exp: 2023-12-31→ Common Stock - Exercise/Conversion
Common Stock
2023-12-31$2.49/sh+1,606$3,999→ 85,585 total - Exercise/Conversion
Common Stock
2023-12-31$2.49/sh+5,020$12,500→ 90,605 total
Footnotes (6)
- [F1]Represents the settlement of restricted stock units (RSUs), awarded for advisory services, which vested on December 31, 2023 through the issuance of shares of Common Stock.
- [F2]Represents the settlement of RSUs, awarded as director compensation, which vested on December 31, 2023 through the issuance of shares of Common Stock.
- [F3]Each RSU is the economic equivalent of one share of Cardio Diagnostics Holdings, Inc. common stock. On December 31, 2023, $14,500 in value of RSUs vested and were settled at the price of $2.49, which was the closing price of the Company Common Stock on the vesting date. The settlement shares are reflected in Table I.
- [F4]On July 1, 2023, the reporting person was awarded $24,000 in value of RSUs, $4,000 in value of which vested on December 31, 2023. Subject to continued service with the Issuer on the vesting date, $2,000 in value of RSUs will vest on January 31, 2024.
- [F5]On June 19, 2023, the reporting person was awarded $50,000 in value of RSUs of which $12,500 vested on December 31, 2023.
- [F6]The RSUs were granted pursuant to the Issuers 2022 Equity Incentive Plan.